Maintenance of the virus-specific T cell equillibrium in chronic MCMV infection

慢性 MCMV 感染中病毒特异性 T 细胞平衡的维持

基本信息

  • 批准号:
    8135989
  • 负责人:
  • 金额:
    $ 10.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-01 至 2013-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cytomegalovirus is a beta-herpesvirus that establishes chronic/persistent infections in the majority of people world-wide. Despite the fact that the virus persists at extremely low levels, the immune system, and T cells in particular, become obsessed with the infection: CMV-specific CD8 T cells can regularly comprise 10% of all CD8 T cells in the peripheral blood of infected individuals. Data from mice infected with murine cytomegalovirus (MCMV) have shown that CDS T cells begin accumulating after acute infection until reaching the high numbers seen in circulation during chronic infection, a process known as memory inflation. In both humans and mice, these inflated T cells bear a phenotype that is indicative of extensive antigen-driven differentiation. Yet the T cells remain functional and retain proliferative potential even at late times post infection. We have recently shown that during chronic infection, these MCMV-specific T cell populations divide only sporadically, are short-lived in circulation and are being constantly replaced as they disappear. Thus, these circulating CMV-specific T cells, that exist in large enough numbers to perturb the total CD8 T cell pool, are highly dynamic. We postulate that this constant decay and replacement of differentiated cells avoids the T cell dysfunction that is seen in other models of chronic infection. Ultimately however, CMV infection is associated with large T cell clonal expansions in aged individuals, suggesting that eventually, the dynamic equilibrium that was established early in chronic infection is lost. These clonal expansions consist of dysfunctional T cells and their presence is associated with an immune risk phenotype in old age. We hypothesize that these expansions arise because some cells divide rather than decay as infected individuals get older. It is important to understand how the dynamic equilibrium is established and maintained in healthy adults in order to understand how it is lost with age. The experiments outlined in this grant are designed to locate and follow the cells that respond to viral antigen and produce differentiated, short-lived progeny during chronic infection and to dissect the impact of viral gene expression on the accumulation of CD8 T cells.
描述(由申请方提供):巨细胞病毒是一种β-疱疹病毒,可在全球大多数人群中造成慢性/持续性感染。尽管病毒持续存在于极低的水平,免疫系统,特别是T细胞,变得痴迷于感染:CMV特异性CD 8 T细胞通常占感染个体外周血中所有CD 8 T细胞的10%。来自感染鼠巨细胞病毒(MCMV)的小鼠的数据显示,CDS T细胞在急性感染后开始积累,直到达到慢性感染期间在循环中看到的高数量,这一过程称为记忆膨胀。在人类和小鼠中,这些膨胀的T细胞具有指示广泛抗原驱动分化的表型。然而,即使在感染后的晚期,T细胞仍保持功能性并保留增殖潜力。我们最近表明,在慢性感染期间,这些MCMV特异性T细胞群仅零星分裂,在循环中寿命很短,并且随着它们的消失而不断被替换。因此,这些以足够大的数量存在以扰乱总CD 8 T细胞库的循环CMV特异性T细胞是高度动态的。我们假设这种分化细胞的不断衰减和替换避免了在其他慢性感染模型中看到的T细胞功能障碍。然而,最终,CMV感染与老年个体中的大T细胞克隆扩增相关,这表明最终,在慢性感染早期建立的动态平衡丢失。这些克隆扩增由功能失调的T细胞组成,它们的存在与老年人的免疫风险表型相关。我们假设这些扩张的出现是因为随着感染者变老,一些细胞分裂而不是衰变。重要的是要了解如何建立和维持健康成年人的动态平衡,以了解它是如何随着年龄的增长而失去的。本研究中概述的实验旨在定位和跟踪对病毒抗原有反应的细胞,并在慢性感染期间产生分化的短命后代,并剖析病毒基因表达对CD 8 T细胞积累的影响。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Stochastic Expansions Maintain the Clonal Stability of CD8+ T Cell Populations Undergoing Memory Inflation Driven by Murine Cytomegalovirus.
随机扩增维持经历鼠巨细胞病毒驱动的记忆膨胀的 CD8 T 细胞群的克隆稳定性。
  • DOI:
    10.4049/jimmunol.1900455
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Smith,CorinneJ;Venturi,Vanessa;Quigley,MaireF;Turula,Holly;Gostick,Emma;Ladell,Kristin;Hill,BrennaJ;Himelfarb,Danielle;Quinn,KylieM;Greenaway,HuiYee;Dang,ThurstonHY;Seder,RobertA;Douek,DanielC;Hill,AnnB;Davenport,Mil
  • 通讯作者:
    Davenport,Mil
Resolving the titer of murine cytomegalovirus by plaque assay using the M2-10B4 cell line and a low viscosity overlay.
通过使用M2-10B4细胞系和低粘度覆盖层来解决鼠巨细胞病毒的滴度。
  • DOI:
    10.1186/1743-422x-11-71
  • 发表时间:
    2014-04-18
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Zurbach KA;Moghbeli T;Snyder CM
  • 通讯作者:
    Snyder CM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher M Snyder其他文献

Christopher M Snyder的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher M Snyder', 18)}}的其他基金

An animal model for cytomegalovirus-induced pathology in the developing retina
发育中视网膜中巨细胞病毒诱导病理学的动物模型
  • 批准号:
    10432947
  • 财政年份:
    2022
  • 资助金额:
    $ 10.8万
  • 项目类别:
An animal model for cytomegalovirus-induced pathology in the developing retina
发育中视网膜中巨细胞病毒诱导病理学的动物模型
  • 批准号:
    10559671
  • 财政年份:
    2022
  • 资助金额:
    $ 10.8万
  • 项目类别:
T cell control of MCMV and tissue-localized immune suppression
T 细胞对 MCMV 的控制和组织局部免疫抑制
  • 批准号:
    10579272
  • 财政年份:
    2020
  • 资助金额:
    $ 10.8万
  • 项目类别:
T cell control of MCMV and tissue-localized immune suppression
T 细胞对 MCMV 的控制和组织局部免疫抑制
  • 批准号:
    10348755
  • 财政年份:
    2020
  • 资助金额:
    $ 10.8万
  • 项目类别:
Selection of inflationary and tissue-resident T cells during MCMV infection
MCMV 感染期间膨胀和组织驻留 T 细胞的选择
  • 批准号:
    8986152
  • 财政年份:
    2014
  • 资助金额:
    $ 10.8万
  • 项目类别:
Selection of inflationary and tissue-resident T cells during MCMV infection
MCMV 感染期间膨胀和组织驻留 T 细胞的选择
  • 批准号:
    8651139
  • 财政年份:
    2014
  • 资助金额:
    $ 10.8万
  • 项目类别:
Selection of inflationary and tissue-resident T cells during MCMV infection
MCMV 感染期间膨胀和组织驻留 T 细胞的选择
  • 批准号:
    9198197
  • 财政年份:
    2014
  • 资助金额:
    $ 10.8万
  • 项目类别:
Selection of inflationary and tissue-resident T cells during MCMV infection
MCMV 感染期间膨胀和组织驻留 T 细胞的选择
  • 批准号:
    8786495
  • 财政年份:
    2014
  • 资助金额:
    $ 10.8万
  • 项目类别:
Selection of inflationary and tissue-resident T cells during MCMV infection
MCMV 感染期间膨胀和组织驻留 T 细胞的选择
  • 批准号:
    8690204
  • 财政年份:
    2013
  • 资助金额:
    $ 10.8万
  • 项目类别:
Synergy between BRAF inhibition, tumor-localized T cells and a persistent vaccine
BRAF 抑制、肿瘤定位 T 细胞和持久性疫苗之间的协同作用
  • 批准号:
    8635992
  • 财政年份:
    2013
  • 资助金额:
    $ 10.8万
  • 项目类别:

相似海外基金

Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 10.8万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10576370
  • 财政年份:
    2022
  • 资助金额:
    $ 10.8万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10387023
  • 财政年份:
    2022
  • 资助金额:
    $ 10.8万
  • 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10248409
  • 财政年份:
    2019
  • 资助金额:
    $ 10.8万
  • 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
  • 批准号:
    nhmrc : GNT1163111
  • 财政年份:
    2019
  • 资助金额:
    $ 10.8万
  • 项目类别:
    Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10462684
  • 财政年份:
    2019
  • 资助金额:
    $ 10.8万
  • 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
  • 批准号:
    398018062
  • 财政年份:
    2018
  • 资助金额:
    $ 10.8万
  • 项目类别:
    Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9308643
  • 财政年份:
    2017
  • 资助金额:
    $ 10.8万
  • 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9447149
  • 财政年份:
    2017
  • 资助金额:
    $ 10.8万
  • 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
  • 批准号:
    8893915
  • 财政年份:
    2014
  • 资助金额:
    $ 10.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了